Testing of some N-lost-compounds by screening test for cytostatic activity
Keitel, R.; Pöge, A.W.
Archiv für Geschwulstforschung 43(2): 168-171
1974
ISSN/ISBN: 0003-911X PMID: 4849880 Document Number: 76287
Document emailed within 1 workday
Related Documents
Giełdanowski, J.; Steuden, W. 1981: Screening system for the evaluation of preparations with potential cytostatic and immunotropic activity. III. Derivatives of hexahydrochromate Archivum Immunologiae et Therapiae Experimentalis 29(2): 267-271Chmel', I.V.; Bibikova, M.V.; Spiridonova, I.A.; Tertov, V.V.; Katlinskiĭ, A.V. 2004: Screening of natural compounds with hypolipidemic activity Antibiotiki i Khimioterapiia 49(8-9): 8-12
Didier, E.S.; Maddry, J.A.; Kwong, C.D.; Green, L.C.; Snowden, K.F.; Shadduck, J.A. 1998: Screening of compounds for antimicrosporidial activity in vitro Folia Parasitologica 45(2): 129-139
Zabelin, N.N.; Gribauskas, P.S.; Moĭseenok, A.G. 1988: Ultrasonic coagulometry as a method of testing compounds with antiplasmin activity Biofizika 33(2): 226-228
Babu, B.V.; Moorti, R.; Pugazhenthi, S.; Prabhu, K.M.; Murthy, P.S. 1988: Alloxan recovered rabbits as animal model for screening for hypoglycaemic activity of compounds Indian Journal of Biochemistry and Biophysics 25(6): 714-718
Khudoley, V.V.; Mizgireuv, I.; Pliss, G.B. 1987: The study of mutagenic activity of carcinogens and other chemical agents with Salmonella typhimurium assays: testing of 126 compounds Archiv für Geschwulstforschung 57(6): 453-462
Ory, J.P. 1994: Diabetic nephropathy: screening by testing for micro-albuminuria with reagent strips (Micral-Test) Presse Medicale 23(6): 300
Stresser, D.M.; Blanchard, A.P.; Turner, S.D.; Erve, J.C.; Dandeneau, A.A.; Miller, V.P.; Crespi, C.L. 2000: Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(12): 1440-1448
Kawai, T. 1998: Activity of ISO/TC212, clinical laboratory testing and in vitro diagnostic test systems Rinsho Byori. Japanese Journal of Clinical Pathology 46(10): 961-967
Horáková, L.; Dráber, P.; Nouza, K. 1978: "Nucleolar test" as a system for screening and analysis of immunosuppressive activity of chemical and biological agents Folia Biologica 24(1): 39-50
Snyder, H.; Yeldandi, V.V.; Prem Kumar, G.; Liao, C.; Lakshmi, V.; Gandham, S.R.; Muppudi, U.; Oruganti, G.; Schneider, J.A. 2012: Field-based video pre-test counseling, oral testing, and telephonic post-test counseling: implementation of an HIV field testing package among high-risk Indian men Aids Education and Prevention: Official Publication of the International Society for Aids Education 24(4): 309-326
Hiramatsu, K.; Yamada, T.; Yukimura, Y.; Komiya, I.; Ichikawa, K.; Ishihara, M.; Nagata, H.; Izumiyama, T. 1981: A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients Archives of Internal Medicine 141(12): 1589-1593
Spitzbart, H.; Schmidt, F. 1970: Results of in vitro culturing of ovarian neoplasms and testing with cytostatic agents Zentralblatt für Gynakologie 92(7): 201-205
Král, V.; Hajdúch, M.; Neoral, C.; Klein, J.; Mihál, V.; Orel, M.; Aujeský, R.; Vyslouzil, K.; Cwiertka, K.; Kolek, V.; Nosková, V. 2000: Significance and possibilities of cytostatic treatment of malignant tumors: testing the effects of cytostatics Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 79(3): 134-138
Sadof, M.D.; Woods, E.R.; Emans, S.J. 1987: Dipstick leukocyte esterase activity in first-catch urine specimens. a useful screening test for detecting sexually transmitted disease in the adolescent male JAMA 258(14): 1932-1934
Jarvis, J.N.; Meintjes, G.; Wood, R.; Harrison, T.S. 2010: Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme Aids 24(8): 1233-1235
Okajima, O. 1983: Studies on the printing color and the screening efficiency of the Ishihara test for color blindness. II. Evaluation of the screening efficiency of the Ishihara test published in 1979 and 1980 and the criterion of the detection Nippon Ganka Gakkai Zasshi 87(5): 341-345
Wildhagen, M.F.; Christiaens, G.C.; Habbema, J.D. 1996: Serum screening in pregnant women for Down syndrome and open neural-tube defects; testing against the Health Council criteria for genetic screening Nederlands Tijdschrift Voor Geneeskunde 140(2): 85-89
Holloway, S.M.; Porteous, M.E.; Fitzpatrick, D.R.; Crosbie, A.E.; Cetnarskyj, R.; Warner, J.; Barron, L. 1998: Presymptomatic testing for Huntington's disease by linkage and by direct mutation analysis: comparison of uptake of testing and characteristics of test applicants Genetic Counseling 9(2): 103-111
Ludwig, H.; Fritz, E. 1981: Individualized chemotherapy in multiple myeloma by cytostatic drug sensitivity testing of colony-forming stem cells Anticancer Research 1(6): 329-334